Plasma nuclear and mitochondrial DNA levels, and markers of inflammation, shock, and organ damage in patients with septic shock

Shock

Volumn 45, Issue 6, 2016, Pages 607-612

  Timmermans, Kim ^a,b,c   Kox, Matthijs ^a,c   Scheffer, Gert Jan ^b   Pickkers, Peter ^a,c  

^a Department of Intensive Care Medicine ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell free DNA; DAMPs; Mitochondrial DNA; Nuclear DNA; Sepsis; Septic shock

Indexed keywords

BILIRUBIN; CELL NUCLEUS DNA; CREATININE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MITOCHONDRIAL DNA; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXPERIMENTAL ENDOTOXEMIA; FEMALE; HUMAN; INFLAMMATION; INFUSION RATE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORGAN INJURY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; BLOOD; MIDDLE AGED; MORTALITY; NORMAL HUMAN; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHOCK; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CYTOKINES; DNA, MITOCHONDRIAL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHOCK; SHOCK, SEPTIC;

EID: 84952685076     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000549     Document Type: Article

References (22)

1. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 369(21):2063, 2013.
2. Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P: Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunos-timulation. Time for a paradigm change? Am J Respir Crit Care Med 187(12):1287-1293, 2013.
3. Gentile LF, Moldawer LL: DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis. Shock 39(1):113-114, 2013.
4. Sursal T, Stearns-Kurosawa DJ, Itagaki K, Oh SY, Sun S, Kurosawa S, Hauser CJ: Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock 39(1):55-62, 2013.
5. Schwarzenbach H, Hoon DS, Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11(6):426-437, 2011.
6. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P: About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313(1-2):139-142, 2001.
7. Breitbach S, Tug S, Simon P: Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med 42(7):565-586, 2012.
8. van der Vaart M, Pretorius PJ, Circulating DNA: Its origin and fluctuation. Ann N Y Acad Sci 1137:18-26, 2008.
9. Margulis L, Bermudes D: Symbiosis as a mechanism of evolution: status of cell symbiosis theory. Symbiosis 1:101-124, 1985.
10. Kaczmarek A, Vandenabeele P, Krysko DV: Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38(2):209-223, 2013.
11. Kung CT, Hsiao SY, Tsai TC, Su CM, Chang WN, Huang CR, Wang HC, Lin WC, Chang HW, Lin YJ, et al.: Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med 10:130, 2012.
12. Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, et al.: Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med 10(12):e1001577, 2013.
13. Anel R, Kumar A: Human endotoxemia and human sepsis: limits to the model. Crit Care 9(2):151-152, 2005.
14. Suffredini AF, Noveck RJ: Human endotoxin administration as an experimental model in drug development. Clin Pharmacol Ther 96(4):418-422, 2014.
15. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, Huang DT, Osborn T, Stevens D, Talan DA, P. Emergency Department Sepsis Education and G. Strategies to Improve Survival Working. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48(1):28-54, 2006.
16. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, Sccm/Esicm/Accp/Ats/Sis. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250-1256, 2003.
17. Kox M, van Eijk LT, Zwaag J, van den Wildenberg J, Sweep FC, van der Hoeven JG, Pickkers P: Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proc Natl Acad Sci USA 111(20):7379-7384, 2014.
18. Dorresteijn MJ, van Eijk LT, Netea MG, Smits P, van der Hoeven JG, Pickkers P: Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res 11(5):287-293, 2005.
19. Garcia-Olmo DC, Garcia-Olmo D: Biological role of cell-free nucleic acids in cancer: the theory of genometastasis. Crit Rev Oncog 18(1-2):153-161, 2013.
20. Galeazzi M, Morozzi G, Piccini M, Chen J, Bellisai F, Fineschi S, Marcolongo R: Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmun Rev 2(1):50-55, 2003.
21. Beyer C, Stearns NA, Giessl A, Distler JH, Schett G, Pisetsky DS: The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun 18(5):727-737, 2012.
22. Mai SH, Khan M, Dwivedi DJ, Ross CA, Zhou J, Gould TJ, Gross PL, Weitz JI, Fox-Robichaud AE, Liaw PC, G. Canadian Critical Care Translational Biology. Delayed but not early treatment with DNase reduces organ damage and improves outcome in a murine model of sepsis. Shock 44(2):166-672, 2015.